Abstract
We would like to discuss the article recently published in The Journal of Rheumatology, entitled "Immunoglobulin A Vasculitis Following COVID-19: A French Multicenter Case Series" by Ramdani et al.1 This case series of individuals who developed IgA vasculitis (IgAV) after contracting SARS-CoV-2 describes the formation of IgAV shortly after coronavirus disease 2019 (COVID-19) infection; however, it was unable to completely rule out a coincidental connection between these 2 events.1
